Idoxuridine: Clinical Trials

11 trials of Idoxuridine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown, 1 withdrawn. 4 Phase 2, 4 Phase 3, 3 Phase 4, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Withdrawn 1
Phase 34Completed 4
Phase 43Unknown 2, Completed 1
Not applicable1Completed 1
Phase 11Completed 1

Follow Idoxuridine: new trials by email Literature Review of Idoxuridine trials Research Report on Idoxuridine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
Botulinum toxin type A, placebo - Migraine Disorders
Phase 3CompletedSt. Olavs Hospital1702019-10-012026-08-11
Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis
botulinum toxin A, saline - Base-of-thumb Osteoarthritis
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris602018-11-292025-09-05
Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
Botulinum toxin type A, 0.9% Sodium Chloride Injection - Pain, Head, Pain Syndrome
Phase 3CompletedWeill Medical College of Cornell University752018-08-312023-02-14
Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
Botulinum Toxin Type A 25 IU, Botulinum Toxin Type A 12.5 IU - Cluster Headache
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology102017-04-182021-06-23
Feasibility Pilot for the ReBOO-trial
Intragastric botulinum toxin type A - Obesity
Phase 2CompletedSt. Olavs Hospital102017-03-142020-09-22
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
Onabotulinumtoxin A (BoNT), belladonna, Morphine - Overactive Bladder, Urinary Urge Incontinence
Phase 4CompletedEdgar LeClaire, MD262015-11-012018-09-20
Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
Intravesical injection of Botulinum A Toxin, Bladder overdistension, Placebo - Painful Bladder Syndrome (PBS)
Phase 4UnknownUniversity Of Perugia302010-01-012011-04-20
Botulinum A Toxin in Patients With Parkinson's Disease
Intravesical injection of Botulinum A toxin - Parkinson's Disease, Multiple System Atrophy
Phase 4UnknownUniversity Of Perugia202008-06-012009-01-15
A Prospective Study of Autologous Fat Grafting for Breast Augmentation
breast implants, Liposuction, fat grafting - Breast Augmentation, Fat Grafting
Not applicableCompletedGeorgetown University132008-03-012013-02-15
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
ketorolac acetate, fluorometholone, artificial lacrimal tears - Glaucoma, Trabeculectomy
Phase 3CompletedUniversitaire Ziekenhuizen KU Leuven622005-07-012009-05-29
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine - Leukemia
Phase 2WithdrawnRush University Medical Center1998-04-012021-10-14

Conditions studied

Cystitis, Interstitial (2)  ·  Urinary Bladder, Overactive (2)  ·  Cluster Headache (1)  ·  Fibrosis (1)  ·  Ganglion Cysts (1)  ·  Glaucoma (1)  ·  Headache (1)  ·  Leukemia (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Migraine Disorders (1)  ·  Multiple System Atrophy (1)

Sponsors

St. Olavs Hospital (2)  ·  University Of Perugia (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Edgar LeClaire, MD (1)  ·  Georgetown University (1)  ·  Norwegian University of Science and Technology (1)  ·  Rush University Medical Center (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (4)  ·  Norway (3)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)

Top investigators

Antonella Giannantoni, M.D. (1)  ·  Edgar LeClaire, MD, FACOG (1)  ·  Gwendolyn S Reeve, DMD (1)  ·  Lars Jacob Stovner, prof MD (1)  ·  Michael Miloro, DMD (1)  ·  Philip D. Bonomi, MD (1)  ·  Scott L Spear, MD (1)

Results publications

PMID 29961037, PMID 32583902, PMID 38228287, PMID 38294016, PMID 41727558

NIH funding

2016 (2), 2018 (1), P01CA075606 (1)